Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- N/A
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
- Status
- COMPLETED
- Phase
- PHASE2
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
- Status
- COMPLETED
- Phase
- PHASE2
Blood Samples to Identify Biomarkers of Busulfan
- Status
- TERMINATED
- Phase
- N/A
Quantification of the Time and Effort Required for Peripheral Blood Stem Cell Collection -The European Perspective
- Status
- COMPLETED
- Phase
- N/A
Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Infusion of Allogeneic, 3rd Party CD19-specific T Cells
- Status
- WITHDRAWN
- Phase
- PHASE1
Relaxation and Exercise In Lymphoma Patients
- Status
- COMPLETED
- Phase
- NA
Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Brazilian Network for Lymphoma Registry
- Status
- RECRUITING
- Phase
- N/A
ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1